New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2013
19:36 EDTPATHNuPathe gaps up after Zecuity receives FDA approval
In the extended session Thursday, the shares were trading up at $3.93 after Zecuity was approved by the FDA. At current levels, next resistance is at $4.15, and then at $4.43. Support is at $3.88.
News For PATH From The Last 14 Days
Check below for free stories on PATH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for PATH

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use